Astellas Pharma Inc - Company Profile
Powered by
All the data and insights you need on Astellas Pharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Astellas Pharma Inc Strategy Report
- Understand Astellas Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Astellas Pharma Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
03 Oct 2022 | Astellas Pharma Enters into Agreement with Pantherna | Partnership | - |
Astellas Pharma Inc
Pantherna Therapeutics GmbH
|
05 Jul 2022 | Mogrify Enters into Research Agreement with Astellas Pharma | Partnership | - |
Astellas Pharma Inc
Mogrify Ltd
|
29 Jun 2022 | Mitobridge Enters into Licensing Agreement with Generian Pharma | Licensing Agreement |
Mitobridge Inc
|
Generian Pharmaceuticals Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward